Search

everythinglearnresearchcommunity

for

Search:↓

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

The conclusion is that small hair follicles cause baldness in macaques, and treatments like antiandrogens and minoxidil can prevent hair loss and promote regrowth.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

Reproductive gynecologists are the main referrers for male infertility evaluations in North America.

Infertile men are more likely to produce sperm with abnormal chromosome numbers, which can affect pregnancy success and embryo health.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Hormone imbalances can cause skin diseases, and understanding these links is important for diagnosis and treatment.

Trilostane effectively treated hair loss in Alaskan Malamutes with no adverse effects.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

Interferon gamma alone can't cause alopecia areata in C3H/HeJ mice.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The compounds tested could potentially treat hair loss and alopecia.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

A topical treatment safely and effectively reduced acne by causing targeted cell death in sebaceous glands without side effects.